| Gene Symbol (Name) | Gender | Age change starts | Age change ends | Tissue | Data transforms | Percentage change | P value |
| 0610011F06Rik (RIKEN cDNA 0610011F06 gene) | Male/Female | 5 | 30 | Kidney | Log2 | -6.0 | <0.001 |
| 0910001L09Rik (RIKEN cDNA 0910001L09 gene) | Male/Female | 8 | 24 | Muscle | Log2 | -6.0 | <0.001 |
| 1110002B05Rik (RIKEN cDNA 1110002B05 gene) | Male/Female | 6 | 22 | Liver | Log2 | 5.0 | <0.001 |
| 1110008P14Rik (RIKEN cDNA 1110008P14 gene) | Male/Female | 5 | 30 | Anatomical System | Log2 | -2.0 | <0.001 |
| 1500001M20Rik (RIKEN cDNA 1500001M20 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | -8.0 | <0.001 |
| 1600015I10Rik (RIKEN cDNA 1600015I10 gene) | Male/Female | 5 | 22 | Brain | Log2 | -53.0 | <0.001 |
| 1600029I14Rik (RIKEN cDNA 1600029I14 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 16.0 | <0.001 |
| 1700006E09Rik (RIKEN cDNA 1700006E09 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 88.0 | <0.001 |
| 1700056E22Rik (RIKEN cDNA 1700056E22 gene) | Male/Female | 2 | 26 | Lung | Log2 | 91.0 | <0.001 |
| 1810044D09Rik (RIKEN cDNA 1810044D09 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 4.0 | <0.001 |
| 2310033P09Rik (RIKEN cDNA 2310033P09 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | -1.0 | <0.001 |
| 2310037I24Rik (RIKEN cDNA 2310037I24 gene) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| 2410017P09Rik (RIKEN cDNA 2410017P09 gene) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| 2610005L07Rik (RIKEN cDNA 2610005L07 gene) | Male/Female | 5 | 22 | Brain | Log2 | 2.0 | <0.001 |
| 2610018G03Rik (RIKEN cDNA 2610018G03 gene) | Male/Female | 8 | 24 | Muscle | Log2 | 5.0 | <0.001 |
| 2610201A13Rik (RIKEN cDNA 2610201A13 gene) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| 2700007P21Rik (RIKEN cDNA 2700007P21 gene) | Male/Female | 8 | 24 | Muscle | Log2 | -6.0 | <0.001 |
| 2810021B07Rik (RIKEN cDNA 2810021B07 gene) | Male/Female | 2 | 26 | Lung | Log2 | 5.0 | <0.001 |
| 2810038L03Rik (RIKEN cDNA 2810038L03 gene) | Male/Female | 5 | 22 | Brain | Log2 | 382.0 | <0.001 |
| 2810405K02Rik (RIKEN cDNA 2810405K02 gene) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| 3830431G21Rik (RIKEN cDNA 3830431G21 gene) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| 4732418C07Rik (RIKEN cDNA 4732418C07 gene) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| 4833411C07Rik (RIKEN cDNA 4833411C07 gene) | Male/Female | 5 | 22 | Brain | Log2 | 114.0 | <0.001 |
| 4930453L07Rik (RIKEN cDNA 4930453L07 gene) | Male/Female | 5 | 22 | Brain | Log2 | -51.0 | <0.001 |
| 4930456G14Rik (RIKEN cDNA 4930456G14 gene) | Male/Female | 2 | 26 | Lung | Log2 | 55.0 | <0.001 |
| 4930517J16Rik (RIKEN cDNA 4930517J16 gene) | Male/Female | 5 | 30 | Anatomical System | Log2 | 146.0 | <0.001 |
| 4930578I06Rik (RIKEN cDNA 4930578I06 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 58.0 | <0.001 |
| 4933433G19Rik (RIKEN cDNA 4933433G19 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | -12.0 | <0.001 |
| 5430427O19Rik (RIKEN cDNA 5430427O19 gene) | Male/Female | 5 | 22 | Brain | Log2 | -84.0 | <0.001 |
| 6720462K09Rik (RIKEN cDNA 6720462K09 gene) | Male/Female | 3 | 12 | Heart | Log2 | -5.0 | <0.001 |
| 8430408G22Rik (RIKEN cDNA 8430408G22 gene) | Male/Female | 2 | 26 | Lung | Log2 | 8.0 | <0.001 |
| 8430436O14Rik (RIKEN cDNA 8430436O14 gene) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| 9030418K01Rik (RIKEN cDNA 9030418K01 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 7.0 | <0.001 |
| 9530001N24Rik (RIKEN cDNA 9530001N24 gene) | Male/Female | 5 | 30 | Kidney | Log2 | -3.0 | <0.001 |
| A130082M07Rik (RIKEN cDNA A130082M07 gene) | Male/Female | 2 | 26 | Lung | Log2 | 19.0 | <0.001 |
| A230006K03Rik (RIKEN cDNA A230006K03 gene) | Male/Female | 8 | 24 | Muscle | Log2 | -16.0 | <0.001 |
| A230038B01Rik (RIKEN cDNA A230038B01 gene) | Male/Female | 5 | 22 | Brain | Log2 | 240.0 | <0.001 |
| A930005H10Rik (RIKEN cDNA A930005H10 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 7.0 | <0.001 |
| Abat (4-aminobutyrate aminotransferase) | Male/Female | 3 | 23 | Hematological System | Log2 | 45.0 | <0.001 |
| Abcc1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | Male/Female | 2 | 26 | Lung | Log2 | 2.0 | <0.001 |
| Abhd14a (abhydrolase domain containing 14A) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Accn1 (amiloride-sensitive cation channel 1, neuronal (degenerin)) | Male/Female | 2 | 26 | Lung | Log2 | 57.0 | <0.001 |
| Acot7 (acyl-CoA thioesterase 7) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Acsm2 (acyl-CoA synthetase medium-chain family member 2) | Male/Female | 3 | 23 | Hematological System | Log2 | -29.0 | <0.001 |
| Acsm2 (acyl-CoA synthetase medium-chain family member 2) | Male/Female | 5 | 30 | Kidney | Log2 | -5.0 | <0.001 |
| Acss1 (acyl-CoA synthetase short-chain family member 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | -2.0 | <0.001 |
| Acta1 (actin, alpha 1, skeletal muscle) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 55.0 | <0.001 |
| Actc1 (actin, alpha, cardiac muscle 1) | Male/Female | 8 | 24 | Muscle | Log2 | -13.0 | <0.001 |
| Actr6 (ARP6 actin-related protein 6 homolog (yeast)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 7.0 | <0.001 |
| Acyp2 (acylphosphatase 2, muscle type) | Male/Female | 5 | 30 | Kidney | Log2 | -7.0 | <0.001 |
| Adam25 (a disintegrin and metallopeptidase domain 25 (testase 2)) | Male/Female | 3 | 23 | Hematological System | Log2 | 9.0 | <0.001 |
| Adamts1 (a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1) | Male/Female | 5 | 30 | Kidney | Log2 | 7.0 | <0.001 |
| Adssl1 (adenylosuccinate synthetase like 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -13.0 | <0.001 |
| Ahcyl1 (S-adenosylhomocysteine hydrolase-like 1) | Male/Female | 5 | 22 | Brain | Log2 | 1.0 | <0.001 |
| Ahcyl1 (S-adenosylhomocysteine hydrolase-like 1) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Ahnak2 (AHNAK nucleoprotein 2) | Male/Female | 3 | 23 | Hematological System | Log2 | 81.0 | <0.001 |
| AI317395 (expressed sequence AI317395) | Male/Female | 2 | 26 | Lung | Log2 | 6.0 | <0.001 |
| AI447881 (expressed sequence AI447881) | Male/Female | 2 | 26 | Lung | Log2 | 6.0 | <0.001 |
| AI596487 (expressed sequence AI596487) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -1.0 | <0.001 |
| Akr1c18 (aldo-keto reductase family 1, member C18) | Male/Female | 4 | 15 | Cochlea | Log2 | -20.0 | <0.001 |
| Alb (albumin) | Male/Female | 5 | 22 | Brain | Log2 | 88.0 | <0.001 |
| Alcam (activated leukocyte cell adhesion molecule) | Male/Female | 3 | 23 | Hematological System | Log2 | 15.0 | <0.001 |
| Aldh1a1 (aldehyde dehydrogenase family 1, subfamily A1) | Male/Female | 8 | 24 | Muscle | Log2 | 6.0 | <0.001 |
| Alox5 (arachidonate 5-lipoxygenase) | Male | 2 | 22 | Heart | |||
| Alox5 (arachidonate 5-lipoxygenase) | Male | 2 | 22 | Heart | |||
| Alox5 (arachidonate 5-lipoxygenase) | Male | 2 | 22 | Heart | |||
| Alox5 (arachidonate 5-lipoxygenase) | Male | 2 | 22 | Cerebellum | |||
| Ammecr1l (AMME chromosomal region gene 1-like) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Amy1 (amylase 1, salivary) | Male/Female | 8 | 24 | Muscle | Log2 | 12.0 | <0.001 |
| Angpt1 (angiopoietin 1) | Male/Female | 8 | 24 | Muscle | Log2 | -16.0 | <0.001 |
| Ank (progressive ankylosis) | Male/Female | 2 | 15 | Hippocampus | Log2 | 1.0 | <0.001 |
| Ankrd26 (ankyrin repeat domain 26) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Antxr2 (anthrax toxin receptor 2) | Male/Female | 3 | 23 | Hematological System | Log2 | -15.0 | <0.001 |
| Anxa2 (annexin A2) | Male/Female | 2 | 15 | Hippocampus | Log2 | 8.0 | <0.001 |
| Anxa2 (annexin A2) | Male/Female | 5 | 30 | Kidney | Log2 | 8.0 | <0.001 |
| Anxa3 (annexin A3) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 23.0 | <0.001 |
| Ap2m1 (adaptor protein complex AP-2, mu1) | Male/Female | 6 | 22 | Liver | Log2 | 1.0 | <0.001 |
| Apln (apelin) | Male/Female | 3 | 23 | Hematological System | Log2 | 13.0 | <0.001 |
| Apobec1 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1) | Male/Female | 5 | 22 | Brain | Log2 | 92.0 | <0.001 |
| Apod (apolipoprotein D) | Male/Female | 5 | 30 | Anatomical System | Log2 | 14.0 | <0.001 |
| Arhgap18 (Rho GTPase activating protein 18) | Male/Female | 2 | 26 | Lung | Log2 | 5.0 | <0.001 |
| Arhgap26 (Rho GTPase activating protein 26) | Male/Female | 2 | 26 | Lung | Log2 | 2.0 | <0.001 |
| Arhgdia (Rho GDP dissociation inhibitor (GDI) alpha) | Male/Female | 6 | 22 | Liver | Log2 | 9.0 | <0.001 |
| Arl1 (ADP-ribosylation factor-like 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 6.0 | <0.001 |
| Arl5a (ADP-ribosylation factor-like 5A) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Armcx1 (armadillo repeat containing, X-linked 1) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Atg12 (autophagy-related 12 (yeast)) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Atg5 (autophagy-related 5 (yeast)) | Male/Female | 6 | 22 | Liver | Log2 | -7.0 | <0.001 |
| Atg9b (ATG9 autophagy related 9 homolog B (S. cerevisiae)) | Male/Female | 3 | 23 | Hematological System | Log2 | 7.0 | <0.001 |
| Atp1b2 (ATPase, Na+/K+ transporting, beta 2 polypeptide) | Male/Female | 5 | 30 | Anatomical System | Log2 | 4.0 | <0.001 |
| Atp5f1 (ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1) | Male/Female | 5 | 30 | Kidney | Log2 | -5.0 | <0.001 |
| Atp5j2 (ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Atp5l (ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g) | Male/Female | 8 | 24 | Muscle | Log2 | -1.0 | <0.001 |
| Atp7a (ATPase, Cu++ transporting, alpha polypeptide) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Atxn2 (ataxin 2) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| AU020206 (expressed sequence AU020206) | Male/Female | 2 | 15 | Hippocampus | Log2 | 10.0 | <0.001 |
| Aurkc (aurora kinase C) | Male/Female | 5 | 22 | Brain | Log2 | -65.0 | <0.001 |
| Avpi1 (arginine vasopressin-induced 1) | Male/Female | 3 | 23 | Hematological System | Log2 | 15.0 | <0.001 |
| B230312A22Rik (RIKEN cDNA B230312A22 gene) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| B2m (beta-2 microglobulin) | Male/Female | 2 | 15 | Hippocampus | Log2 | 6.0 | <0.001 |
| B3galt1 (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1) | Male/Female | 3 | 23 | Hematological System | Log2 | 36.0 | <0.001 |
| B4galnt4 (beta-1,4-N-acetyl-galactosaminyl transferase 4) | Male/Female | 3 | 23 | Hematological System | Log2 | 11.0 | <0.001 |
| BC017643 (cDNA sequence BC017643) | Male/Female | 3 | 23 | Hematological System | Log2 | -9.0 | <0.001 |
| BC026782 (cDNA sequence BC026782) | Male/Female | 5 | 22 | Brain | Log2 | 217.0 | <0.001 |
| BC037703 (cDNA sequence BC037703) | Male/Female | 5 | 22 | Brain | Log2 | 809.0 | <0.001 |
| BC048546 (cDNA sequence BC048546) | Male/Female | 2 | 26 | Lung | Log2 | 18.0 | <0.001 |
| Bcan (brevican) | Male/Female | 5 | 30 | Kidney | Log2 | -6.0 | <0.001 |
| Bcap31 (B-cell receptor-associated protein 31) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 4.0 | <0.001 |
| Bcl3 (B-cell leukemia/lymphoma 3) | Male/Female | 3 | 23 | Hematological System | Log2 | 25.0 | <0.001 |
| Bdnf (brain derived neurotrophic factor) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 5.0 | <0.001 |
| Bdp1 (B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Bgn (biglycan) | Male/Female | 5 | 30 | Kidney | Log2 | 10.0 | <0.001 |
| Birc6 (baculoviral IAP repeat-containing 6) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Bptf (bromodomain PHD finger transcription factor) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Brms1l (breast cancer metastasis-suppressor 1-like) | Male/Female | 2 | 26 | Lung | Log2 | -1.0 | <0.001 |
| C130026I21Rik (RIKEN cDNA C130026I21 gene) | Male/Female | 2 | 26 | Lung | Log2 | 27.0 | <0.001 |
| C130026I21Rik (RIKEN cDNA C130026I21 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | 22.0 | <0.001 |
| C1qa (complement component 1, q subcomponent, alpha polypeptide) | Male/Female | 5 | 30 | Anatomical System | Log2 | 5.0 | <0.001 |
| C1qb (complement component 1, q subcomponent, beta polypeptide) | Male/Female | 2 | 15 | Hippocampus | Log2 | 3.0 | <0.001 |
| C1qb (complement component 1, q subcomponent, beta polypeptide) | Male/Female | 5 | 30 | Kidney | Log2 | 9.0 | <0.001 |
| C1qc (complement component 1, q subcomponent, C chain) | Male/Female | 5 | 30 | Anatomical System | Log2 | 5.0 | <0.001 |
| C1qc (complement component 1, q subcomponent, C chain) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| C1qtnf2 (C1q and tumor necrosis factor related protein 2) | Male/Female | 2 | 26 | Lung | Log2 | -8.0 | <0.001 |
| C1qtnf3 (C1q and tumor necrosis factor related protein 3) | Male/Female | 2 | 26 | Lung | Log2 | -22.0 | <0.001 |
| C3 (complement component 3) | Male/Female | 6 | 22 | Liver | Log2 | 5.0 | <0.001 |
| C430014B12Rik (RIKEN cDNA C430014B12 gene) | Male/Female | 5 | 30 | Kidney | Log2 | 26.0 | <0.001 |
| C4a (complement component 4A (Rodgers blood group)) | Male/Female | 5 | 30 | Anatomical System | Log2 | 26.0 | <0.001 |
| C730048C13Rik (RIKEN cDNA C730048C13 gene) | Male/Female | 5 | 30 | Kidney | Log2 | -7.0 | <0.001 |
| C78197 (expressed sequence C78197) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 16.0 | <0.001 |
| C78339 (expressed sequence C78339) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Camk1d (calcium/calmodulin-dependent protein kinase ID) | Male/Female | 2 | 26 | Lung | Log2 | 6.0 | <0.001 |
| Camk2b (calcium/calmodulin-dependent protein kinase II, beta) | Male/Female | 8 | 24 | Muscle | Log2 | 7.0 | <0.001 |
| Car2 (carbonic anhydrase 2) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Card10 (caspase recruitment domain family, member 10) | Male/Female | 3 | 23 | Hematological System | Log2 | 19.0 | <0.001 |
| Catsper1 (cation channel, sperm associated 1) | Male/Female | 8 | 24 | Muscle | Log2 | -10.0 | <0.001 |
| Cav1 (caveolin 1, caveolae protein) | Male/Female | 5 | 22 | Brain | Log2 | 6.0 | <0.001 |
| Ccbe1 (collagen and calcium binding EGF domains 1) | Male/Female | 3 | 23 | Hematological System | Log2 | 57.0 | <0.001 |
| Ccl19 (chemokine (C-C motif) ligand 19) | Male/Female | 5 | 30 | Kidney | Log2 | 4.0 | <0.001 |
| Ccl21b (chemokine (C-C motif) ligand 21B) | Male/Female | 5 | 30 | Anatomical System | Log2 | 51.0 | <0.001 |
| Ccnf (cyclin F) | Male/Female | 6 | 22 | Liver | Log2 | -3.0 | <0.001 |
| Cct5 (chaperonin containing Tcp1, subunit 5 (epsilon)) | Male/Female | 6 | 22 | Liver | Log2 | 7.0 | <0.001 |
| Cd160 (CD160 antigen) | Male/Female | 8 | 24 | Muscle | Log2 | -6.0 | <0.001 |
| Cd163 (CD163 antigen) | Male/Female | 2 | 26 | Lung | Log2 | 28.0 | <0.001 |
| Cd28 (CD28 antigen) | Male/Female | 2 | 26 | Lung | Log2 | 17.0 | <0.001 |
| Cd38 (CD38 antigen) | Male/Female | 4 | 15 | Cochlea | Log2 | 26.0 | <0.001 |
| Cd74 (CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | Male/Female | 5 | 30 | Kidney | Log2 | 14.0 | <0.001 |
| Cd8b1 (CD8 antigen, beta chain 1) | Male/Female | 2 | 26 | Lung | Log2 | 36.0 | <0.001 |
| Cdh6 (cadherin 6) | Male/Female | 2 | 15 | Hippocampus | Log2 | -9.0 | <0.001 |
| Cdk18 (cyclin-dependent kinase 18) | Male/Female | 6 | 22 | Liver | Log2 | -7.0 | <0.001 |
| Cdkn1a (cyclin-dependent kinase inhibitor 1A (P21)) | Male/Female | 8 | 24 | Muscle | Log2 | 14.0 | <0.001 |
| Cdkn2a (cyclin-dependent kinase inhibitor 2A) | Male/Female | 1 | -1 | Whole Body | |||
| Cebpd (CCAAT/enhancer binding protein (C/EBP), delta) | Male/Female | 3 | 23 | Hematological System | Log2 | 39.0 | <0.001 |
| Cecr5 (cat eye syndrome chromosome region, candidate 5 homolog (human)) | Male/Female | 6 | 22 | Liver | Log2 | 15.0 | <0.001 |
| Cherp (calcium homeostasis endoplasmic reticulum protein) | Male/Female | 6 | 22 | Liver | Log2 | -7.0 | <0.001 |
| Chi3l3 (chitinase 3-like 3) | Male/Female | 3 | 23 | Hematological System | Log2 | -53.0 | <0.001 |
| Chordc1 (cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1) | Male/Female | 2 | 26 | Lung | Log2 | -8.0 | <0.001 |
| Chrnb1 (cholinergic receptor, nicotinic, beta polypeptide 1 (muscle)) | Male/Female | 8 | 24 | Muscle | Log2 | 6.0 | <0.001 |
| Chst2 (carbohydrate sulfotransferase 2) | Male/Female | 2 | 26 | Lung | Log2 | -10.0 | <0.001 |
| Chsy1 (chondroitin sulfate synthase 1) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Chuk (conserved helix-loop-helix ubiquitous kinase) | Male/Female | 5 | 30 | Kidney | Log2 | -10.0 | <0.001 |
| Cideb (cell death-inducing DNA fragmentation factor, alpha subunit-like effector B) | Male/Female | 6 | 22 | Liver | Log2 | -5.0 | <0.001 |
| Ckap2 (cytoskeleton associated protein 2) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Clcn3 (chloride channel 3) | Male/Female | 2 | 26 | Lung | Log2 | 3.0 | <0.001 |
| Clec11a (C-type lectin domain family 11, member a) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Clec1b (C-type lectin domain family 1, member b) | Male/Female | 2 | 26 | Lung | Log2 | 22.0 | <0.001 |
| Clic4 (chloride intracellular channel 4 (mitochondrial)) | Male/Female | 5 | 30 | Anatomical System | Log2 | 4.0 | <0.001 |
| Clic4 (chloride intracellular channel 4 (mitochondrial)) | Male/Female | 6 | 22 | Liver | Log2 | 3.0 | <0.001 |
| Clint1 (clathrin interactor 1) | Male/Female | 8 | 24 | Muscle | Log2 | 5.0 | <0.001 |
| Cmpk1 (cytidine monophosphate (UMP-CMP) kinase 1) | Male/Female | 5 | 30 | Kidney | Log2 | -7.0 | <0.001 |
| Cmtm8 (CKLF-like MARVEL transmembrane domain containing 8) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Cnot8 (CCR4-NOT transcription complex, subunit 8) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Cnpy4 (canopy 4 homolog (zebrafish)) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Cog5 (component of oligomeric golgi complex 5) | Male/Female | 6 | 22 | Liver | Log2 | 52.0 | <0.001 |
| Col16a1 (collagen, type XVI, alpha 1) | Male/Female | 2 | 26 | Lung | Log2 | -8.0 | <0.001 |
| Col1a2 (collagen, type I, alpha 2) | Male/Female | 2 | 26 | Lung | Log2 | -11.0 | <0.001 |
| Col27a1 (collagen, type XXVII, alpha 1) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| Col3a1 (collagen, type III, alpha 1) | Male/Female | 2 | 26 | Lung | Log2 | -11.0 | <0.001 |
| Col6a3 (collagen, type VI, alpha 3) | Male/Female | 2 | 26 | Lung | Log2 | -9.0 | <0.001 |
| Commd4 (COMM domain containing 4) | Male/Female | 2 | 15 | Hippocampus | Log2 | -1.0 | <0.001 |
| Cops5 (COP9 (constitutive photomorphogenic) homolog, subunit 5 (Arabidopsis thaliana)) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Coq5 (coenzyme Q5 homolog, methyltransferase (yeast)) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Coq7 (demethyl-Q 7) | Male/Female | 6 | 22 | Liver | Log2 | 10.0 | <0.001 |
| Cox6a1 (cytochrome c oxidase, subunit VI a, polypeptide 1) | Male/Female | 2 | 26 | Lung | Log2 | 1.0 | <0.001 |
| Cox8b (cytochrome c oxidase, subunit VIIIb) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Cp (ceruloplasmin) | Male/Female | 5 | 30 | Kidney | Log2 | 10.0 | <0.001 |
| Cpeb1 (cytoplasmic polyadenylation element binding protein 1) | Male/Female | 6 | 22 | Liver | Log2 | -53.0 | <0.001 |
| Cpne2 (copine II) | Male/Female | 8 | 24 | Muscle | Log2 | 42.0 | <0.001 |
| Creg1 (cellular repressor of E1A-stimulated genes 1) | Male/Female | 2 | 26 | Lung | Log2 | 3.0 | <0.001 |
| Crlf3 (cytokine receptor-like factor 3) | Male/Female | 5 | 30 | Anatomical System | Log2 | 3.0 | <0.001 |
| Cryba1 (crystallin, beta A1) | Male/Female | 3 | 23 | Hematological System | Log2 | 95.0 | <0.001 |
| Cs (citrate synthase) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 4.0 | <0.001 |
| Csprs (component of Sp100-rs) | Male/Female | 2 | 26 | Lung | Log2 | 27.0 | <0.001 |
| Csprs (component of Sp100-rs) | Male/Female | 3 | 23 | Hematological System | Log2 | 68.0 | <0.001 |
| Csrp1 (cysteine and glycine-rich protein 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 14.0 | <0.001 |
| Ctf1 (cardiotrophin 1) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Ctla2a (cytotoxic T lymphocyte-associated protein 2 alpha) | Male/Female | 2 | 15 | Hippocampus | Log2 | 13.0 | <0.001 |
| Ctse (cathepsin E) | Male/Female | 5 | 30 | Anatomical System | Log2 | -8.0 | <0.001 |
| Ctsk (cathepsin K) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 58.0 | <0.001 |
| Ctss (cathepsin S) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 74.0 | <0.001 |
| Ctss (cathepsin S) | Male/Female | 5 | 30 | Anatomical System | Log2 | 6.0 | <0.001 |
| Ctss (cathepsin S) | Male/Female | 3 | 23 | Hematological System | Log2 | -21.0 | <0.001 |
| Ctss (cathepsin S) | Male/Female | 2 | 15 | Hippocampus | Log2 | 4.0 | <0.001 |
| Ctss (cathepsin S) | Male/Female | 5 | 30 | Kidney | Log2 | 17.0 | <0.001 |
| Ctsz (cathepsin Z) | Male/Female | 5 | 30 | Anatomical System | Log2 | 11.0 | <0.001 |
| Ctsz (cathepsin Z) | Male/Female | 2 | 15 | Hippocampus | Log2 | 6.0 | <0.001 |
| Cttnbp2nl (CTTNBP2 N-terminal like) | Male/Female | 3 | 23 | Hematological System | Log2 | 12.0 | <0.001 |
| Cuta (cutA divalent cation tolerance homolog (E. coli)) | Male/Female | 2 | 15 | Hippocampus | Log2 | -2.0 | <0.001 |
| Cx3cl1 (chemokine (C-X3-C motif) ligand 1) | Male/Female | 5 | 30 | Kidney | Log2 | 17.0 | <0.001 |
| Cx3cl1 (chemokine (C-X3-C motif) ligand 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 10.0 | <0.001 |
| Cx3cl1 (chemokine (C-X3-C motif) ligand 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | -2.0 | <0.001 |
| Cxcl1 (chemokine (C-X-C motif) ligand 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | 33.0 | <0.001 |
| Cxcl13 (chemokine (C-X-C motif) ligand 13) | Male/Female | 2 | 26 | Lung | Log2 | 20.0 | <0.001 |
| Cxcl14 (chemokine (C-X-C motif) ligand 14) | Male/Female | 2 | 26 | Lung | Log2 | -8.0 | <0.001 |
| Cxcr3 (chemokine (C-X-C motif) receptor 3) | Male/Female | 2 | 26 | Lung | Log2 | 20.0 | <0.001 |
| Cyp2c39 (cytochrome P450, family 2, subfamily c, polypeptide 39) | Male/Female | 6 | 22 | Liver | Log2 | -8.0 | <0.001 |
| Cyp7a1 (cytochrome P450, family 7, subfamily a, polypeptide 1) | Male/Female | 3 | 23 | Hematological System | Log2 | 35.0 | <0.001 |
| Cysltr2 (cysteinyl leukotriene receptor 2) | Male/Female | 3 | 23 | Hematological System | Log2 | 17.0 | <0.001 |
| D030056L22Rik (RIKEN cDNA D030056L22 gene) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -7.0 | <0.001 |
| D0H4S114 (DNA segment, human D4S114) | Male/Female | 2 | 26 | Lung | Log2 | -12.0 | <0.001 |
| D0H4S114 (DNA segment, human D4S114) | Male/Female | 2 | 15 | Hippocampus | Log2 | -5.0 | <0.001 |
| D10627 (cDNA sequence D10627) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -8.0 | <0.001 |
| D1Ertd705e (DNA segment, Chr 1, ERATO Doi 705, expressed) | Male/Female | 3 | 23 | Hematological System | Log2 | 61.0 | <0.001 |
| D4Bwg0951e (DNA segment, Chr 4, Brigham & Women's Genetics 0951 expressed) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| D630004K10Rik (RIKEN cDNA D630004K10 gene) | Male/Female | 3 | 23 | Hematological System | Log2 | -16.0 | <0.001 |
| Dap3 (death associated protein 3) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -3.0 | <0.001 |
| Dctn2 (dynactin 2) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 9.0 | <0.001 |
| Dctpp1 (dCTP pyrophosphatase 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | -7.0 | <0.001 |
| Ddah2 (dimethylarginine dimethylaminohydrolase 2) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Ddah2 (dimethylarginine dimethylaminohydrolase 2) | Male/Female | 2 | 15 | Hippocampus | Log2 | -3.0 | <0.001 |
| Ddi2 (DNA-damage inducible protein 2) | Male/Female | 5 | 22 | Brain | Log2 | -3.0 | <0.001 |
| Ddx3y (DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked) | Male/Female | 8 | 24 | Muscle | Log2 | 8.0 | <0.001 |
| Dhcr7 (7-dehydrocholesterol reductase) | Male/Female | 6 | 22 | Liver | Log2 | 19.0 | <0.001 |
| Dhx40 (DEAH (Asp-Glu-Ala-His) box polypeptide 40) | Male/Female | 3 | 23 | Hematological System | Log2 | 12.0 | <0.001 |
| Dip2b (DIP2 disco-interacting protein 2 homolog B (Drosophila)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -1.0 | <0.001 |
| Dmbt1 (deleted in malignant brain tumors 1) | Male/Female | 4 | 15 | Cochlea | Log2 | 1.0 | <0.001 |
| Dmrtc1a (DMRT-like family C1a) | Male/Female | 3 | 23 | Hematological System | Log2 | 13.0 | <0.001 |
| Dnaja1 (DnaJ (Hsp40) homolog, subfamily A, member 1) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Dnajb1 (DnaJ (Hsp40) homolog, subfamily B, member 1) | Male/Female | 2 | 26 | Lung | Log2 | -10.0 | <0.001 |
| Dnm3 (dynamin 3) | Male/Female | 3 | 23 | Hematological System | Log2 | 18.0 | <0.001 |
| Dnmt3a (DNA methyltransferase 3A) | Male | 2 | 22 | Heart | |||
| Dok1 (docking protein 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -12.0 | <0.001 |
| Dram1 (DNA-damage regulated autophagy modulator 1) | Male/Female | 3 | 23 | Hematological System | Log2 | -12.0 | <0.001 |
| Dram2 (VDNA-damage regulated autophagy modulator 2) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 16.0 | <0.001 |
| Dusp22 (dual specificity phosphatase 22) | Male/Female | 3 | 23 | Hematological System | Log2 | -18.0 | <0.001 |
| Dusp6 (dual specificity phosphatase 6) | Male/Female | 2 | 15 | Hippocampus | Log2 | -3.0 | <0.001 |
| Dut (deoxyuridine triphosphatase) | Male/Female | 5 | 30 | Anatomical System | Log2 | -25.0 | <0.001 |
| E030003E18Rik (RIKEN cDNA E030003E18 gene) | Male/Female | 5 | 30 | Kidney | Log2 | 11.0 | <0.001 |
| Ear5 (eosinophil-associated, ribonuclease A family, member 5) | Male/Female | 5 | 22 | Brain | Log2 | 3385.0 | <0.001 |
| Ebi3 (Epstein-Barr virus induced gene 3) | Male/Female | 3 | 23 | Hematological System | Log2 | -27.0 | <0.001 |
| Egf (epidermal growth factor) | Male/Female | 5 | 30 | Kidney | Log2 | -2.0 | <0.001 |
| Ehd3 (EH-domain containing 3) | Male/Female | 3 | 23 | Hematological System | Log2 | 33.0 | <0.001 |
| Eif2a (eukaryotic translation initiation factor 2a) | Male/Female | 3 | 12 | Heart | Log2 | -8.0 | <0.001 |
| Eif2s1 (eukaryotic translation initiation factor 2, subunit 1 alpha) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -3.0 | <0.001 |
| Eif2s1 (eukaryotic translation initiation factor 2, subunit 1 alpha) | Male/Female | 5 | 30 | Kidney | Log2 | -4.0 | <0.001 |
| Eif4a2 (eukaryotic translation initiation factor 4A2) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 5.0 | <0.001 |
| Ell2 (elongation factor RNA polymerase II 2) | Male/Female | 8 | 24 | Muscle | Log2 | 7.0 | <0.001 |
| En1 (engrailed 1) | Male/Female | 8 | 24 | Muscle | Log2 | 8.0 | <0.001 |
| Entpd2 (ectonucleoside triphosphate diphosphohydrolase 2) | Male/Female | 6 | 22 | Liver | Log2 | 23.0 | <0.001 |
| Entpd7 (ectonucleoside triphosphate diphosphohydrolase 7) | Male/Female | 8 | 24 | Muscle | Log2 | -9.0 | <0.001 |
| Epb4.1l3 (erythrocyte protein band 4.1-like 3) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Epc1 (enhancer of polycomb homolog 1 (Drosophila)) | Male/Female | 6 | 22 | Liver | Log2 | 2.0 | <0.001 |
| Eps8l1 (EPS8-like 1) | Male/Female | 5 | 22 | Brain | Log2 | 152.0 | <0.001 |
| Eral1 (Era (G-protein)-like 1 (E. coli)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -2.0 | <0.001 |
| Erbb3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) | Male/Female | 5 | 30 | Anatomical System | Log2 | 8.0 | <0.001 |
| Etf1 (eukaryotic translation termination factor 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 2.0 | <0.001 |
| Etv1 (ets variant gene 1) | Male/Female | 3 | 23 | Hematological System | Log2 | -35.0 | <0.001 |
| Exoc6b (exocyst complex component 6B) | Male/Female | 3 | 23 | Hematological System | Log2 | 11.0 | <0.001 |
| Exosc7 (exosome component 7) | Male/Female | 8 | 24 | Muscle | Log2 | -7.0 | <0.001 |
| Ext1 (exostoses (multiple) 1) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Extl1 (exostoses (multiple)-like 1) | Male/Female | 8 | 24 | Muscle | Log2 | -7.0 | <0.001 |
| F13a1 (coagulation factor XIII, A1 subunit) | Male/Female | 2 | 26 | Lung | Log2 | 8.0 | <0.001 |
| Fabp4 (fatty acid binding protein 4, adipocyte) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 188.0 | <0.001 |
| Fabp5 (fatty acid binding protein 5, epidermal) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 259.0 | <0.001 |
| Fam114a1 (family with sequence similarity 114, member A1) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Fam132a (family with sequence similarity 132, member A) | Male/Female | 5 | 30 | Anatomical System | Log2 | -7.0 | <0.001 |
| Fam13b (family with sequence similarity 13, member B) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 4.0 | <0.001 |
| Fam162b (family with sequence similarity 162, member B) | Male/Female | 2 | 26 | Lung | Log2 | -14.0 | <0.001 |
| Fam176b (family with sequence similarity 176, member B) | Male/Female | 5 | 22 | Brain | Log2 | -9.0 | <0.001 |
| Fam19a5 (family with sequence similarity 19, member A5) | Male/Female | 8 | 24 | Muscle | Log2 | 9.0 | <0.001 |
| Fam83h (family with sequence similarity 83, member H) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -3.0 | <0.001 |
| Fbn2 (fibrillin 2) | Male/Female | 8 | 24 | Muscle | Log2 | -31.0 | <0.001 |
| Fbxw4 (F-box and WD-40 domain protein 4) | Male/Female | 3 | 23 | Hematological System | Log2 | -12.0 | <0.001 |
| Fdps (farnesyl diphosphate synthetase) | Male/Female | 8 | 24 | Muscle | Log2 | -7.0 | <0.001 |
| Fdx1 (ferredoxin 1) | Male/Female | 5 | 30 | Kidney | Log2 | -7.0 | <0.001 |
| Fermt3 (fermitin family homolog 3 (Drosophila)) | Male/Female | 2 | 26 | Lung | Log2 | 14.0 | <0.001 |
| Fgf13 (fibroblast growth factor 13) | Male/Female | 2 | 26 | Lung | Log2 | 28.0 | <0.001 |
| Fggy (FGGY carbohydrate kinase domain containing) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 17.0 | <0.001 |
| Fhl1 (four and a half LIM domains 1) | Male/Female | 5 | 30 | Kidney | Log2 | -4.0 | <0.001 |
| Fhod1 (formin homology 2 domain containing 1) | Male/Female | 2 | 26 | Lung | Log2 | -8.0 | <0.001 |
| Fmc1 (formation of mitochondrial complexes 1 homolog (S. cerevisiae)) | Male/Female | 5 | 30 | Anatomical System | Log2 | -1.0 | <0.001 |
| Fn1 (fibronectin 1) | Male/Female | 3 | 12 | Heart | Log2 | 8.0 | <0.001 |
| Fnbp4 (formin binding protein 4) | Male/Female | 5 | 30 | Kidney | Log2 | -9.0 | <0.001 |
| Fosb (FBJ osteosarcoma oncogene B) | Male/Female | 2 | 26 | Lung | Log2 | -13.0 | <0.001 |
| Fosl2 (fos-like antigen 2) | Male/Female | 6 | 22 | Liver | Log2 | -40.0 | <0.001 |
| Foxa3 (forkhead box A3) | Male/Female | 6 | 22 | Liver | Log2 | 13.0 | <0.001 |
| Foxl1 (forkhead box L1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -1.0 | <0.001 |
| Foxred2 (FAD-dependent oxidoreductase domain containing 2) | Male/Female | 2 | 26 | Lung | Log2 | 89.0 | <0.001 |
| Fryl (furry homolog-like (Drosophila)) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Frzb (frizzled-related protein) | Male/Female | 8 | 24 | Muscle | Log2 | -12.0 | <0.001 |
| Fut9 (fucosyltransferase 9) | Male/Female | 5 | 22 | Brain | Log2 | -2.0 | <0.001 |
| Fzd2 (frizzled homolog 2 (Drosophila)) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Gab1 (growth factor receptor bound protein 2-associated protein 1) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Gabra3 (gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3) | Male/Female | 5 | 30 | Anatomical System | Log2 | 5.0 | <0.001 |
| Gabra4 (gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4) | Male/Female | 3 | 23 | Hematological System | Log2 | 252.0 | <0.001 |
| Gad1 (glutamic acid decarboxylase 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | 1.0 | <0.001 |
| Gadd45a (growth arrest and DNA-damage-inducible 45 alpha) | Male/Female | 3 | 12 | Heart | Log2 | -5.0 | <0.001 |
| Gapdhs (glyceraldehyde-3-phosphate dehydrogenase, spermatogenic) | Male/Female | 6 | 22 | Liver | Log2 | -14.0 | <0.001 |
| Gas2l2 (growth arrest-specific 2 like 2) | Male/Female | 2 | 26 | Lung | Log2 | 15.0 | <0.001 |
| Gas2l3 (growth arrest-specific 2 like 3) | Male/Female | 3 | 23 | Hematological System | Log2 | 14.0 | <0.001 |
| Gas5 (growth arrest specific 5) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Gcat (glycine C-acetyltransferase (2-amino-3-ketobutyrate-coenzyme A ligase)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 10.0 | <0.001 |
| Gclc (glutamate-cysteine ligase, catalytic subunit) | Male/Female | 6 | 12 | Liver | |||
| Gclm (glutamate-cysteine ligase, modifier subunit) | Male/Female | 5 | 30 | Kidney | Log2 | -4.0 | <0.001 |
| Gcsh (glycine cleavage system protein H (aminomethyl carrier)) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Gdpd5 (glycerophosphodiester phosphodiesterase domain containing 5) | Male/Female | 8 | 24 | Muscle | Log2 | 23.0 | <0.001 |
| Gem (GTP binding protein (gene overexpressed in skeletal muscle)) | Male/Female | 2 | 26 | Lung | Log2 | -13.0 | <0.001 |
| Gfap (glial fibrillary acidic protein) | Male/Female | 2 | 15 | Hippocampus | Log2 | 4.0 | <0.001 |
| Gfap (glial fibrillary acidic protein) | Male/Female | 5 | 30 | Anatomical System | Log2 | 11.0 | <0.001 |
| Gfra2 (glial cell line derived neurotrophic factor family receptor alpha 2) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Ggt1 (gamma-glutamyltransferase 1) | Male/Female | 2 | 26 | Lung | Log2 | 7.0 | <0.001 |
| Ghitm (growth hormone inducible transmembrane protein) | Male/Female | 5 | 30 | Kidney | Log2 | -3.0 | <0.001 |
| Gkap1 (G kinase anchoring protein 1) | Male/Female | 8 | 24 | Muscle | Log2 | 8.0 | <0.001 |
| Glo1 (glyoxalase 1) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Gltp (glycolipid transfer protein) | Male/Female | 5 | 30 | Anatomical System | Log2 | 5.0 | <0.001 |
| Gm11346 (predicted gene 11346) | Male/Female | 2 | 26 | Lung | Log2 | 55.0 | <0.001 |
| Gm5537 (predicted gene 5537) | Male/Female | 5 | 30 | Kidney | Log2 | -4.0 | <0.001 |
| Gm885 (predicted gene 885) | Male/Female | 5 | 22 | Brain | Log2 | 674.0 | <0.001 |
| Gna11 (guanine nucleotide binding protein, alpha 11) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Gnpda1 (glucosamine-6-phosphate deaminase 1) | Male/Female | 6 | 22 | Liver | Log2 | -6.0 | <0.001 |
| Gns (glucosamine (N-acetyl)-6-sulfatase) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Gp1ba (glycoprotein 1b, alpha polypeptide) | Male/Female | 2 | 26 | Lung | Log2 | 20.0 | <0.001 |
| Gp1bb (glycoprotein Ib, beta polypeptide) | Male/Female | 2 | 26 | Lung | Log2 | 22.0 | <0.001 |
| Gp5 (glycoprotein 5 (platelet)) | Male/Female | 2 | 26 | Lung | Log2 | 15.0 | <0.001 |
| Gp6 (glycoprotein 6 (platelet)) | Male/Female | 2 | 26 | Lung | Log2 | 16.0 | <0.001 |
| Gpbp1 (GC-rich promoter binding protein 1) | Male/Female | 5 | 30 | Kidney | Log2 | -2.0 | <0.001 |
| Gpcpd1 (glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae)) | Male/Female | 2 | 26 | Lung | Log2 | 8.0 | <0.001 |
| Gpd1 (glycerol-3-phosphate dehydrogenase 1 (soluble)) | Male/Female | 8 | 24 | Muscle | Log2 | -6.0 | <0.001 |
| Gpx3 (glutathione peroxidase 3) | Male/Female | 3 | 23 | Hematological System | Log2 | 45.0 | <0.001 |
| Grcc10 (gene rich cluster, C10 gene) | Male/Female | 5 | 30 | Anatomical System | Log2 | 3.0 | <0.001 |
| Grhpr (glyoxylate reductase/hydroxypyruvate reductase) | Male/Female | 8 | 24 | Muscle | Log2 | -1.0 | <0.001 |
| Gse1 (genetic suppressor element 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | -31.0 | <0.001 |
| Gtf2i (general transcription factor II I) | Male/Female | 2 | 15 | Hippocampus | Log2 | -1.0 | <0.001 |
| Gtpbp2 (GTP binding protein 2) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Gzmm (granzyme M (lymphocyte met-ase 1)) | Male/Female | 2 | 26 | Lung | Log2 | 16.0 | <0.001 |
| H2-Aa (histocompatibility 2, class II antigen A, alpha) | Male/Female | 6 | 22 | Liver | Log2 | 53.0 | <0.001 |
| H2-Ab1 (histocompatibility 2, class II antigen A, beta 1) | Male/Female | 5 | 30 | Kidney | Log2 | 20.0 | <0.001 |
| H2-Ab1 (histocompatibility 2, class II antigen A, beta 1) | Male/Female | 6 | 22 | Liver | Log2 | 30.0 | <0.001 |
| H2-Ea (histocompatibility 2, class II antigen E alpha) | Male/Female | 5 | 30 | Kidney | Log2 | 9.0 | <0.001 |
| H2-Eb1 (histocompatibility 2, class II antigen E beta) | Male/Female | 5 | 30 | Kidney | Log2 | 7.0 | <0.001 |
| H2-Ob (histocompatibility 2, O region beta locus) | Male/Female | 5 | 30 | Kidney | Log2 | 12.0 | <0.001 |
| H3f3a (H3 histone, family 3A) | Male/Female | 5 | 30 | Kidney | Log2 | -2.0 | <0.001 |
| Heyl (hairy/enhancer-of-split related with YRPW motif-like) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Hist1h1c (histone cluster 1, H1c) | Male/Female | 2 | 26 | Lung | Log2 | 7.0 | <0.001 |
| Hist1h1c (histone cluster 1, H1c) | Male/Female | 6 | 22 | Liver | Log2 | 26.0 | <0.001 |
| Hist1h3a (histone cluster 1, H3a) | Male/Female | 2 | 26 | Lung | Log2 | 11.0 | <0.001 |
| Hjurp (Holliday junction recognition protein) | Male/Female | 2 | 26 | Lung | Log2 | 4.0 | <0.001 |
| Hmgcs1 (3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1) | Male/Female | 5 | 30 | Kidney | Log2 | -4.0 | <0.001 |
| Hoxb4 (homeobox B4) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Hsbp1 (heat shock factor binding protein 1) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Hsd17b11 (hydroxysteroid (17-beta) dehydrogenase 11) | Male/Female | 5 | 30 | Kidney | Log2 | -7.0 | <0.001 |
| Hsd17b7 (hydroxysteroid (17-beta) dehydrogenase 7) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Hsd3b2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2) | Male/Female | 5 | 30 | Kidney | Log2 | -13.0 | <0.001 |
| Hsfy2 (heat shock transcription factor, Y linked 2) | Male/Female | 5 | 22 | Brain | Log2 | -81.0 | <0.001 |
| Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | -1.0 | <0.001 |
| Htra1 (HtrA serine peptidase 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Icmt (isoprenylcysteine carboxyl methyltransferase) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Ifi205 (interferon activated gene 205) | Male/Female | 3 | 23 | Hematological System | Log2 | -3.0 | <0.001 |
| Ifi35 (interferon-induced protein 35) | Male/Female | 8 | 24 | Muscle | Log2 | -10.0 | <0.001 |
| Igdcc3 (immunoglobulin superfamily, DCC subclass, member 3) | Male/Female | 6 | 22 | Liver | Log2 | -5.0 | <0.001 |
| Igh-1a (immunoglobulin heavy chain 1a (serum IgG2a)) | Male/Female | 5 | 30 | Kidney | Log2 | 24.0 | <0.001 |
| Igh-2 (immunoglobulin heavy chain 2 (serum IgA)) | Male/Female | 5 | 30 | Kidney | Log2 | 47.0 | <0.001 |
| Igh-VJ558 (immunoglobulin heavy chain (J558 family)) | Male/Female | 5 | 30 | Kidney | Log2 | 19.0 | <0.001 |
| Igj (immunoglobulin joining chain) | Male/Female | 5 | 30 | Kidney | Log2 | 38.0 | <0.001 |
| Igj (immunoglobulin joining chain) | Male/Female | 6 | 22 | Liver | Log2 | 14.0 | <0.001 |
| Igj (immunoglobulin joining chain) | Male/Female | 5 | 22 | Brain | Log2 | 51.0 | <0.001 |
| Igk-V8 (immunoglobulin kappa chain variable 8 (V8)) | Male/Female | 5 | 30 | Kidney | Log2 | 51.0 | <0.001 |
| Il18rap (interleukin 18 receptor accessory protein) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -14.0 | <0.001 |
| Il22ra2 (interleukin 22 receptor, alpha 2) | Male/Female | 2 | 26 | Lung | Log2 | -14.0 | <0.001 |
| Impdh2 (inosine 5'-phosphate dehydrogenase 2) | Male/Female | 6 | 22 | Liver | Log2 | 6.0 | <0.001 |
| Ing2 (inhibitor of growth family, member 2) | Male/Female | 8 | 24 | Muscle | Log2 | 7.0 | <0.001 |
| Ing4 (inhibitor of growth family, member 4) | Male/Female | 8 | 24 | Muscle | Log2 | -8.0 | <0.001 |
| Inha (inhibin alpha) | Male/Female | 5 | 30 | Anatomical System | Log2 | -5.0 | <0.001 |
| Inmt (indolethylamine N-methyltransferase) | Male/Female | 4 | 15 | Cochlea | Log2 | -6.0 | <0.001 |
| Iqcf1 (IQ motif containing F1) | Male/Female | 5 | 22 | Brain | Log2 | -98.0 | <0.001 |
| Irs1 (insulin receptor substrate 1) | Male/Female | 2 | 26 | Lung | Log2 | -7.0 | <0.001 |
| Irx2 (Iroquois related homeobox 2 (Drosophila)) | Male/Female | 2 | 26 | Lung | Log2 | -8.0 | <0.001 |
| Isca1 (iron-sulfur cluster assembly 1 homolog (S. cerevisiae)) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Itgb2 (integrin beta 2) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 306.0 | <0.001 |
| Itgb5 (integrin beta 5) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Itm2a (integral membrane protein 2A) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Kcnab1 (potassium voltage-gated channel, shaker-related subfamily, beta member 1) | Male/Female | 8 | 24 | Muscle | Log2 | 7.0 | <0.001 |
| Kctd3 (potassium channel tetramerisation domain containing 3) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| Kdelr1 (KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1) | Male/Female | 6 | 22 | Liver | Log2 | 2.0 | <0.001 |
| Kdr (kinase insert domain protein receptor) | Male/Female | 3 | 23 | Hematological System | Log2 | 28.0 | <0.001 |
| Kif2a (kinesin family member 2A) | Male/Female | 2 | 26 | Lung | Log2 | 6.0 | <0.001 |
| Kif6 (kinesin family member 6) | Male/Female | 3 | 23 | Hematological System | Log2 | 33.0 | <0.001 |
| Klk1b16 (kallikrein 1-related peptidase b16) | Male/Female | 5 | 30 | Kidney | Log2 | -4.0 | <0.001 |
| Klk1b5 (kallikrein 1-related peptidase b5) | Male/Female | 2 | 26 | Lung | Log2 | -36.0 | <0.001 |
| Klk1b9 (kallikrein 1-related peptidase b9) | Male/Female | 5 | 30 | Kidney | Log2 | -6.0 | <0.001 |
| Klk6 (kallikrein related-peptidase 6) | Male/Female | 5 | 30 | Anatomical System | Log2 | 68.0 | <0.001 |
| Klra19 (killer cell lectin-like receptor, subfamily A, member 19) | Male/Female | 5 | 22 | Brain | Log2 | -97.0 | <0.001 |
| Klraq1 (KLRAQ motif containing 1) | Male/Female | 6 | 22 | Liver | Log2 | 2.0 | <0.001 |
| Kpna2 (karyopherin (importin) alpha 2) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Krt15 (keratin 15) | Male/Female | 6 | 22 | Liver | Log2 | -26.0 | <0.001 |
| L1cam (L1 cell adhesion molecule) | Male/Female | 5 | 30 | Anatomical System | Log2 | -12.0 | <0.001 |
| Lamb1-1 (laminin B1 subunit 1) | Male/Female | 8 | 24 | Muscle | Log2 | -8.0 | <0.001 |
| Lamp1 (lysosomal-associated membrane protein 1) | Male/Female | 5 | 22 | Brain | Log2 | 2.0 | <0.001 |
| Lamp1 (lysosomal-associated membrane protein 1) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Lat (linker for activation of T cells) | Male/Female | 2 | 26 | Lung | Log2 | 18.0 | <0.001 |
| Lgals3 (lectin, galactose binding, soluble 3) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 141.0 | <0.001 |
| Lman1 (lectin, mannose-binding, 1) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Lnx1 (ligand of numb-protein X 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | -4.0 | <0.001 |
| LOC380889 (LOC380889) | Male/Female | 5 | 22 | Brain | Log2 | -80.0 | <0.001 |
| LOC641050 (LOC641050) | Male/Female | 2 | 26 | Lung | Log2 | 30.0 | <0.001 |
| LOC67527 (LOC67527) | Male/Female | 2 | 26 | Lung | Log2 | 20.0 | <0.001 |
| Loxl4 (lysyl oxidase-like 4) | Male/Female | 5 | 22 | Brain | Log2 | -48.0 | <0.001 |
| Lpin1 (lipin 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 5.0 | <0.001 |
| Lpl (lipoprotein lipase) | Male/Female | 5 | 30 | Kidney | Log2 | -6.0 | <0.001 |
| Lrrc28 (leucine rich repeat containing 28) | Male/Female | 2 | 26 | Lung | Log2 | 2.0 | <0.001 |
| Lrrc63 (leucine rich repeat containing 63) | Male/Female | 5 | 22 | Brain | Log2 | -87.0 | <0.001 |
| Lrrc69 (leucine rich repeat containing 69) | Male/Female | 5 | 22 | Brain | Log2 | 197.0 | <0.001 |
| Ltbp3 (latent transforming growth factor beta binding protein 3) | Male/Female | 2 | 26 | Lung | Log2 | -9.0 | <0.001 |
| Ltf (lactotransferrin) | Male/Female | 2 | 15 | Hippocampus | Log2 | 23.0 | <0.001 |
| Ly6a (lymphocyte antigen 6 complex, locus A) | Male/Female | 6 | 22 | Liver | Log2 | 17.0 | <0.001 |
| Ly86 (lymphocyte antigen 86) | Male/Female | 2 | 15 | Hippocampus | Log2 | 8.0 | <0.001 |
| Lypla1 (lysophospholipase 1) | Male/Female | 5 | 30 | Kidney | Log2 | -5.0 | <0.001 |
| Lyz1 (lysozyme 1) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 82.0 | <0.001 |
| Lyz1 (lysozyme 1) | Male/Female | 5 | 30 | Anatomical System | Log2 | 82.0 | <0.001 |
| Lyz2 (lysozyme 2) | Male/Female | 5 | 30 | Kidney | Log2 | 13.0 | <0.001 |
| Maged2 (melanoma antigen, family D, 2) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 2.0 | <0.001 |
| Magoh (mago-nashi homolog, proliferation-associated (Drosophila)) | Male/Female | 5 | 30 | Kidney | Log2 | -9.0 | <0.001 |
| Mal (myelin and lymphocyte protein, T-cell differentiation protein) | Male/Female | 5 | 30 | Anatomical System | Log2 | 3.0 | <0.001 |
| Mamdc2 (MAM domain containing 2) | Male/Female | 3 | 23 | Hematological System | Log2 | -7.0 | <0.001 |
| Map2k2 (mitogen-activated protein kinase kinase 2) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Map2k6 (mitogen-activated protein kinase kinase 6) | Male/Female | 8 | 24 | Muscle | Log2 | -8.0 | <0.001 |
| Map3k9 (mitogen-activated protein kinase kinase kinase 9) | Male/Female | 3 | 23 | Hematological System | Log2 | 16.0 | <0.001 |
| Map4k2 (mitogen-activated protein kinase kinase kinase kinase 2) | Male/Female | 5 | 30 | Anatomical System | Log2 | -19.0 | <0.001 |
| March7 (membrane-associated ring finger (C3HC4) 7) | Male/Female | 2 | 26 | Lung | Log2 | 4.0 | <0.001 |
| March7 (membrane-associated ring finger (C3HC4) 7) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Mbd2 (methyl-CpG binding domain protein 2) | Male/Female | 8 | 24 | Muscle | Log2 | 5.0 | <0.001 |
| Mbd6 (methyl-CpG binding domain protein 6) | Male/Female | 8 | 24 | Muscle | Log2 | 6.0 | <0.001 |
| Mbl2 (mannose-binding lectin (protein C) 2) | Male/Female | 6 | 22 | Liver | Log2 | 4.0 | <0.001 |
| Mcfd2 (multiple coagulation factor deficiency 2) | Male/Female | 6 | 22 | Liver | Log2 | 0.0 | <0.001 |
| Mdm4 (transformed mouse 3T3 cell double minute 4) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -25.0 | <0.001 |
| Meis2 (Meis homeobox 2) | Male/Female | 3 | 23 | Hematological System | Log2 | 17.0 | <0.001 |
| Meox1 (mesenchyme homeobox 1) | Male/Female | 2 | 26 | Lung | Log2 | -19.0 | <0.001 |
| Mesdc2 (mesoderm development candidate 2) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Mettl2 (methyltransferase like 2) | Male/Female | 5 | 22 | Brain | Log2 | -5.0 | <0.001 |
| Mfsd7b (major facilitator superfamily domain containing 7B) | Male/Female | 3 | 23 | Hematological System | Log2 | 5.0 | <0.001 |
| Mgp (matrix Gla protein) | Male/Female | 5 | 30 | Kidney | Log2 | 12.0 | <0.001 |
| Miip (migration and invasion inhibitory protein) | Male/Female | 8 | 24 | Muscle | Log2 | -6.0 | <0.001 |
| Mmp14 (matrix metallopeptidase 14 (membrane-inserted)) | Male/Female | 6 | 22 | Liver | Log2 | 5.0 | <0.001 |
| Mmrn1 (multimerin 1) | Male/Female | 2 | 26 | Lung | Log2 | 9.0 | <0.001 |
| Mn1 (meningioma 1) | Male/Female | 3 | 23 | Hematological System | Log2 | -10.0 | <0.001 |
| Mocos (molybdenum cofactor sulfurase) | Male/Female | 3 | 23 | Hematological System | Log2 | 18.0 | <0.001 |
| Mogs (mannosyl-oligosaccharide glucosidase) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Morf4l2 (mortality factor 4 like 2) | Male/Female | 6 | 22 | Liver | Log2 | 4.0 | <0.001 |
| Mos (Moloney sarcoma oncogene) | Male/Female | 6 | 22 | Liver | Log2 | -28.0 | <0.001 |
| Mpdu1 (mannose-P-dolichol utilization defect 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 3.0 | <0.001 |
| Mpeg1 (macrophage expressed gene 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 7.0 | <0.001 |
| Mrgpra4 (MAS-related GPR, member A4) | Male/Female | 5 | 22 | Brain | Log2 | -92.0 | <0.001 |
| Mrp63 (mitochondrial ribosomal protein 63) | Male/Female | 5 | 30 | Anatomical System | Log2 | -27.0 | <0.001 |
| Mrps12 (mitochondrial ribosomal protein S12) | Male/Female | 6 | 22 | Liver | Log2 | 5.0 | <0.001 |
| Mrps23 (mitochondrial ribosomal protein S23) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Msl2 (Male-specific lethal 2 homolog (Drosophila)) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Mtap (methylthioadenosine phosphorylase) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Mthfd1 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, ) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Mtm1 (X-linked myotubular myopathy gene 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -14.0 | <0.001 |
| Mtor (mechanistic target of rapamycin (serine/threonine kinase)) | Male/Female | 5 | 30 | Kidney | Log2 | -3.0 | <0.001 |
| Mxi1 (Max interacting protein 1) | Male/Female | 2 | 26 | Lung | Log2 | 4.0 | <0.001 |
| Mybph (myosin binding protein H) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 37.0 | <0.001 |
| Myl6 (myosin, light polypeptide 6, alkali, smooth muscle and non-muscle) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Myl9 (myosin, light polypeptide 9, regulatory) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Mylk (myosin, light polypeptide kinase) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| Myoz1 (myozenin 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -1.0 | <0.001 |
| Napsa (napsin A aspartic peptidase) | Male/Female | 5 | 30 | Kidney | Log2 | -1.0 | <0.001 |
| Narf (nuclear prelamin A recognition factor) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Nat15 (N-acetyltransferase 15 (GCN5-related, putative)) | Male/Female | 2 | 15 | Hippocampus | Log2 | -1.0 | <0.001 |
| Nav1 (neuron navigator 1) | Male/Female | 3 | 23 | Hematological System | Log2 | 25.0 | <0.001 |
| Nbea (neurobeachin) | Male/Female | 8 | 24 | Muscle | Log2 | 10.0 | <0.001 |
| Ncald (neurocalcin delta) | Male/Female | 2 | 26 | Lung | Log2 | -7.0 | <0.001 |
| Ndc80 (NDC80 homolog, kinetochore complex component (S. cerevisiae)) | Male/Female | 3 | 23 | Hematological System | Log2 | -20.0 | <0.001 |
| Ndufb3 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3) | Male/Female | 5 | 30 | Kidney | Log2 | -3.0 | <0.001 |
| Ndufb4 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4) | Male/Female | 8 | 24 | Muscle | Log2 | -1.0 | <0.001 |
| Ndufb5 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5) | Male/Female | 5 | 30 | Anatomical System | Log2 | -1.0 | <0.001 |
| Ndufc1 (NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Nedd8 (neural precursor cell expressed, developmentally down-regulated gene 8) | Male/Female | 3 | 12 | Heart | Log2 | -3.0 | <0.001 |
| Neil1 (nei endonuclease VIII-like 1 (E. coli)) | Male/Female | 3 | 23 | Hematological System | Log2 | 18.0 | <0.001 |
| Nek7 (NIMA (never in mitosis gene a)-related expressed kinase 7) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Neto2 (neuropilin (NRP) and tolloid (TLL)-like 2) | Male/Female | 3 | 23 | Hematological System | Log2 | -19.0 | <0.001 |
| Nfs1 (nitrogen fixation gene 1 (S. cerevisiae)) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Nisch (nischarin) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 3.0 | <0.001 |
| Nit2 (nitrilase family, member 2) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Nktr (natural killer tumor recognition sequence) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Nmnat2 (nicotinamide nucleotide adenylyltransferase 2) | Male/Female | 2 | 26 | Lung | Log2 | -7.0 | <0.001 |
| Nnt (nicotinamide nucleotide transhydrogenase) | Male/Female | 5 | 30 | Kidney | Log2 | -11.0 | <0.001 |
| Nptn (neuroplastin) | Male/Female | 2 | 26 | Lung | Log2 | 2.0 | <0.001 |
| Npy (neuropeptide Y) | Male/Female | 2 | 15 | Hippocampus | Log2 | 3.0 | <0.001 |
| Nrp1 (neuropilin 1) | Male/Female | 5 | 22 | Brain | Log2 | -5.0 | <0.001 |
| Nsmce4a (non-SMC element 4 homolog A (S. cerevisiae)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -6.0 | <0.001 |
| Ntf3 (neurotrophin 3) | Male/Female | 3 | 23 | Hematological System | Log2 | 34.0 | <0.001 |
| Nucks1 (nuclear casein kinase and cyclin-dependent kinase substrate 1) | Male/Female | 6 | 22 | Liver | Log2 | 6.0 | <0.001 |
| Nudt19 (nudix (nucleoside diphosphate linked moiety X)-type motif 19) | Male/Female | 5 | 30 | Kidney | Log2 | -5.0 | <0.001 |
| Nynrin (NYN domain and retroviral integrase containing) | Male/Female | 3 | 12 | Heart | Log2 | 8.0 | <0.001 |
| Odc1 (ornithine decarboxylase, structural 1) | Male/Female | 5 | 30 | Kidney | Log2 | -8.0 | <0.001 |
| Opn1lw (opsin 1 (cone pigments), long-wave-sensitive) | Male/Female | 3 | 12 | Heart | Log2 | 19.0 | <0.001 |
| Orc6l (origin recognition complex, subunit 6-like (S. cerevisiae)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -7.0 | <0.001 |
| Osmr (oncostatin M receptor) | Male/Female | 2 | 15 | Hippocampus | Log2 | 9.0 | <0.001 |
| Ovca2 (candidate tumor suppressor in ovarian cancer 2) | Male/Female | 2 | 26 | Lung | Log2 | 4.0 | <0.001 |
| Oxtr (oxytocin receptor) | Male/Female | 4 | 15 | Cochlea | Log2 | 19.0 | <0.001 |
| Panx1 (pannexin 1) | Male/Female | 8 | 24 | Muscle | Log2 | 28.0 | <0.001 |
| Pard6a (par-6 (partitioning defective 6,) homolog alpha (C. elegans)) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Pbx2 (pre B-cell leukemia transcription factor 2) | Male/Female | 6 | 22 | Liver | Log2 | 28.0 | <0.001 |
| Pcdh12 (protocadherin 12) | Male/Female | 2 | 26 | Lung | Log2 | -20.0 | <0.001 |
| Pcdhb21 (protocadherin beta 21) | Male/Female | 3 | 23 | Hematological System | Log2 | 75.0 | <0.001 |
| Pcdhb9 (protocadherin beta 9) | Male/Female | 5 | 22 | Brain | Log2 | 7.0 | <0.001 |
| Pcp4l1 (Purkinje cell protein 4-like 1) | Male/Female | 2 | 26 | Lung | Log2 | 3.0 | <0.001 |
| Pdcd4 (programmed cell death 4) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Pde4b (phosphodiesterase 4B, cAMP specific) | Male/Female | 8 | 24 | Muscle | Log2 | 7.0 | <0.001 |
| Pdgfra (platelet derived growth factor receptor, alpha polypeptide) | Male/Female | 0 | 12 | Pancreas | |||
| Pdk4 (pyruvate dehydrogenase kinase, isoenzyme 4) | Male/Female | 2 | 15 | Hippocampus | Log2 | 6.0 | <0.001 |
| Peli1 (pellino 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 3.0 | <0.001 |
| Pes1 (pescadillo homolog 1, containing BRCT domain (zebrafish)) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Pgam2 (phosphoglycerate mutase 2) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Pgf (placental growth factor) | Male/Female | 5 | 22 | Brain | Log2 | -42.0 | <0.001 |
| Pglyrp1 (peptidoglycan recognition protein 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 8.0 | <0.001 |
| Phb (prohibitin) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Phf13 (PHD finger protein 13) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -5.0 | <0.001 |
| Phf16 (PHD finger protein 16) | Male/Female | 2 | 26 | Lung | Log2 | -7.0 | <0.001 |
| Phldb2 (pleckstrin homology-like domain, family B, member 2) | Male/Female | 3 | 23 | Hematological System | Log2 | -8.0 | <0.001 |
| Phpt1 (phosphohistidine phosphatase 1) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Pigr (polymeric immunoglobulin receptor) | Male/Female | 5 | 30 | Kidney | Log2 | 6.0 | <0.001 |
| Pisd-ps3 (phosphatidylserine decarboxylase, pseudogene 3) | Male/Female | 2 | 26 | Lung | Log2 | 9.0 | <0.001 |
| Pitx2 (paired-like homeodomain transcription factor 2) | Male/Female | 3 | 23 | Hematological System | Log2 | -17.0 | <0.001 |
| Pkm2 (pyruvate kinase, muscle) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Pkp2 (plakophilin 2) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 12.0 | <0.001 |
| Plac9 (placenta specific 9) | Male/Female | 8 | 24 | Muscle | Log2 | -7.0 | <0.001 |
| Plek (pleckstrin) | Male/Female | 2 | 26 | Lung | Log2 | 13.0 | <0.001 |
| Plin4 (perilipin 4) | Male/Female | 6 | 22 | Liver | Log2 | -29.0 | <0.001 |
| Plk1s1 (polo-like kinase 1 substrate 1) | Male/Female | 5 | 22 | Brain | Log2 | 7.0 | <0.001 |
| Pmp22 (peripheral myelin protein 22) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Pnp (purine-nucleoside phosphorylase) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 8.0 | <0.001 |
| Polr2b (polymerase (RNA) II (DNA directed) polypeptide B) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Pon2 (paraoxonase 2) | Male/Female | 5 | 30 | Kidney | Log2 | -8.0 | <0.001 |
| Postn (periostin, osteoblast specific factor) | Male/Female | 3 | 23 | Hematological System | Log2 | -39.0 | <0.001 |
| Ppbp (pro-platelet basic protein) | Male/Female | 3 | 23 | Hematological System | Log2 | -27.0 | <0.001 |
| Ppbp (pro-platelet basic protein) | Male/Female | 2 | 26 | Lung | Log2 | 11.0 | <0.001 |
| Ppcdc (phosphopantothenoylcysteine decarboxylase) | Male/Female | 4 | 15 | Cochlea | Log2 | 6.0 | <0.001 |
| Ppp1r14a (protein phosphatase 1, regulatory (inhibitor) subunit 14A) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Pramef8 (PRAME family member 8) | Male/Female | 2 | 26 | Lung | Log2 | 2.0 | <0.001 |
| Prkar2b (protein kinase, cAMP dependent regulatory, type II beta) | Male/Female | 2 | 26 | Lung | Log2 | 10.0 | <0.001 |
| Prkrir (protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repr) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -5.0 | <0.001 |
| Prodh (proline dehydrogenase) | Male/Female | 2 | 26 | Lung | Log2 | 5.0 | <0.001 |
| Prom1 (prominin 1) | Male/Female | 5 | 30 | Kidney | Log2 | 8.0 | <0.001 |
| Prpf38a (PRP38 pre-mRNA processing factor 38 (yeast) domain containing A) | Male/Female | 5 | 22 | Brain | Log2 | 2.0 | <0.001 |
| Prpf6 (PRP6 pre-mRNA splicing factor 6 homolog (yeast)) | Male/Female | 5 | 30 | Anatomical System | Log2 | -1.0 | <0.001 |
| Psmb10 (proteasome (prosome, macropain) subunit, beta type 10) | Male/Female | 6 | 22 | Liver | Log2 | 6.0 | <0.001 |
| Psme1 (proteasome (prosome, macropain) 28 subunit, alpha) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Ptk2b (PTK2 protein tyrosine kinase 2 beta) | Male/Female | 2 | 26 | Lung | Log2 | 9.0 | <0.001 |
| Ptpro (protein tyrosine phosphatase, receptor type, O) | Male/Female | 2 | 15 | Hippocampus | Log2 | -5.0 | <0.001 |
| Ptprr (protein tyrosine phosphatase, receptor type, R) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Qrsl1 (glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | -3.0 | <0.001 |
| Rab31 (RAB31, member RAS oncogene family) | Male/Female | 5 | 30 | Kidney | Log2 | 6.0 | <0.001 |
| Rab40b (Rab40b, member RAS oncogene family) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Rab40b (Rab40b, member RAS oncogene family) | Male/Female | 3 | 23 | Hematological System | Log2 | 18.0 | <0.001 |
| Rabl5 (RAB, member of RAS oncogene family-like 5) | Male/Female | 2 | 26 | Lung | Log2 | 3.0 | <0.001 |
| Rad23b (RAD23b homolog (S. cerevisiae)) | Male/Female | 5 | 30 | Anatomical System | Log2 | -1.0 | <0.001 |
| Rad51ap1 (RAD51 associated protein 1) | Male/Female | 2 | 26 | Lung | Log2 | -11.0 | <0.001 |
| Ralgapa2 (Ral GTPase activating protein, alpha subunit 2 (catalytic)) | Male/Female | 2 | 26 | Lung | Log2 | 7.0 | <0.001 |
| Rasd2 (RASD family, member 2) | Male/Female | 8 | 24 | Muscle | Log2 | 7.0 | <0.001 |
| Rbm3 (RNA binding motif protein 3) | Male/Female | 2 | 26 | Lung | Log2 | -9.0 | <0.001 |
| Rbm3 (RNA binding motif protein 3) | Male/Female | 2 | 15 | Hippocampus | Log2 | 3.0 | <0.001 |
| Rbp1 (retinol binding protein 1, cellular) | Male/Female | 6 | 22 | Liver | Log2 | 33.0 | <0.001 |
| Rcbtb2 (regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Reep6 (receptor accessory protein 6) | Male/Female | 6 | 22 | Liver | Log2 | -5.0 | <0.001 |
| Rell1 (RELT-like 1) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Rem1 (rad and gem related GTP binding protein 1) | Male/Female | 8 | 24 | Muscle | Log2 | -17.0 | <0.001 |
| Rfc5 (replication factor C (activator 1) 5) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -13.0 | <0.001 |
| Rftn2 (raftlin family member 2) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Rgs18 (regulator of G-protein signaling 18) | Male/Female | 2 | 26 | Lung | Log2 | 18.0 | <0.001 |
| Rhob (ras homolog gene family, member B) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Rin2 (Ras and Rab interactor 2) | Male/Female | 2 | 15 | Hippocampus | Log2 | 7.0 | <0.001 |
| Rnf187 (ring finger protein 187) | Male/Female | 8 | 24 | Muscle | Log2 | 3.0 | <0.001 |
| Rnf6 (ring finger protein (C3H2C3 type) 6) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Rpl37 (ribosomal protein L37) | Male/Female | 6 | 22 | Liver | Log2 | 4.0 | <0.001 |
| Rpl3l (ribosomal protein L3-like) | Male/Female | 8 | 24 | Muscle | Log2 | -4.0 | <0.001 |
| Rprd1b (regulation of nuclear pre-mRNA domain containing 1B) | Male/Female | 6 | 22 | Liver | Log2 | 10.0 | <0.001 |
| Rrbp1 (ribosome binding protein 1) | Male/Female | 6 | 22 | Liver | Log2 | 6.0 | <0.001 |
| Rrm2 (ribonucleotide reductase M2) | Male/Female | 2 | 15 | Hippocampus | Log2 | -14.0 | <0.001 |
| Rrp1 (ribosomal RNA processing 1 homolog (S. cerevisiae)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 5.0 | <0.001 |
| Runx1t1 (runt-related transcription factor 1; translocated to, 1 (cyclin D-related)) | Male/Female | 3 | 23 | Hematological System | Log2 | 17.0 | <0.001 |
| Rybp (RING1 and YY1 binding protein) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Ryr1 (ryanodine receptor 1, skeletal muscle) | Male/Female | 5 | 30 | Anatomical System | Log2 | -9.0 | <0.001 |
| S100a6 (S100 calcium binding protein A6 (calcyclin)) | Male/Female | 2 | 15 | Hippocampus | Log2 | 4.0 | <0.001 |
| S100a8 (S100 calcium binding protein A8 (calgranulin A)) | Male/Female | 3 | 23 | Hematological System | Log2 | -40.0 | <0.001 |
| S100a9 (S100 calcium binding protein A9 (calgranulin B)) | Male/Female | 2 | 15 | Hippocampus | Log2 | 33.0 | <0.001 |
| S100b (S100 protein, beta polypeptide, neural) | Male/Female | 2 | 15 | Hippocampus | Log2 | 4.0 | <0.001 |
| Saa1 (serum amyloid A 1) | Male/Female | 3 | 23 | Hematological System | Log2 | 118.0 | <0.001 |
| Sap30l (SAP30-like) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -4.0 | <0.001 |
| Scamp2 (secretory carrier membrane protein 2) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 4.0 | <0.001 |
| Scyl1 (SCY1-like 1 (S. cerevisiae)) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Sec61a1 (Sec61 alpha 1 subunit (S. cerevisiae)) | Male/Female | 2 | 15 | Hippocampus | Log2 | -1.0 | <0.001 |
| Seh1l (SEH1-like (S. cerevisiae) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Sema4d (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (se) | Male/Female | 5 | 30 | Kidney | Log2 | 4.0 | <0.001 |
| Senp6 (SUMO/sentrin specific peptidase 6) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Sept5 (septin 5) | Male/Female | 3 | 23 | Hematological System | Log2 | 36.0 | <0.001 |
| Sepx1 (selenoprotein X 1) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Serpina3n (serine (or cysteine) peptidase inhibitor, clade A, member 3N) | Male/Female | 2 | 24 | Visual Apparatus | Log2 | 141.0 | <0.001 |
| Serpinf1 (serine (or cysteine) peptidase inhibitor, clade F, member 1) | Male/Female | 8 | 24 | Muscle | Log2 | -8.0 | <0.001 |
| Sfi1 (Sfi1 homolog, spindle assembly associated (yeast)) | Male/Female | 2 | 26 | Lung | Log2 | 10.0 | <0.001 |
| Sfrs5 (splicing factor, arginine/serine-rich 5 (SRp40, HRS)) | Male/Female | 2 | 15 | Hippocampus | Log2 | 3.0 | <0.001 |
| Sgca (sarcoglycan, alpha (dystrophin-associated glycoprotein)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 13.0 | <0.001 |
| Sgk1 (serum/glucocorticoid regulated kinase 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 9.0 | <0.001 |
| Sirt1 (sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae)) | Male | 0 | 15 | Bone Marrow | |||
| Slc17a3 (solute carrier family 17 (sodium phosphate), member 3) | Male/Female | 5 | 22 | Brain | Log2 | 11.0 | <0.001 |
| Slc25a11 (solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), member 11) | Male/Female | 8 | 24 | Muscle | Log2 | -1.0 | <0.001 |
| Slc25a28 (solute carrier family 25, member 28) | Male/Female | 8 | 24 | Muscle | Log2 | 5.0 | <0.001 |
| Slc25a5 (solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5) | Male/Female | 2 | 15 | Hippocampus | Log2 | -2.0 | <0.001 |
| Slc2a1 (solute carrier family 2 (facilitated glucose transporter), member 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 6.0 | <0.001 |
| Slc35a2 (solute carrier family 35 (UDP-galactose transporter), member A2) | Male/Female | 8 | 24 | Muscle | Log2 | -9.0 | <0.001 |
| Slc38a2 (solute carrier family 38, member 2) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Slc6a4 (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | Male/Female | 2 | 26 | Lung | Log2 | 16.0 | <0.001 |
| Slc9a1 (solute carrier family 9 (sodium/hydrogen exchanger), member 1) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Slco4a1 (solute carrier organic anion transporter family, member 4a1) | Male/Female | 3 | 23 | Hematological System | Log2 | 17.0 | <0.001 |
| Slu7 (SLU7 splicing factor homolog (S. cerevisiae)) | Male/Female | 3 | 23 | Hematological System | Log2 | -5.0 | <0.001 |
| Smad1 (MAD homolog 1 (Drosophila)) | Male/Female | 2 | 15 | Hippocampus | Log2 | 4.0 | <0.001 |
| Snd1 (staphylococcal nuclease and tudor domain containing 1) | Male/Female | 3 | 23 | Hematological System | Log2 | -5.0 | <0.001 |
| Snrpd2 (small nuclear ribonucleoprotein D2) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Snx12 (sorting nexin 12) | Male/Female | 8 | 24 | Muscle | Log2 | -3.0 | <0.001 |
| Snx20 (sorting nexin 20) | Male/Female | 8 | 24 | Muscle | Log2 | -7.0 | <0.001 |
| Snx33 (sorting nexin 33) | Male/Female | 3 | 23 | Hematological System | Log2 | 62.0 | <0.001 |
| Sos1 (son of sevenless homolog 1 (Drosophila)) | Male/Female | 2 | 26 | Lung | Log2 | -5.0 | <0.001 |
| Sox10 (SRY-box containing gene 10) | Male/Female | 5 | 30 | Anatomical System | Log2 | 4.0 | <0.001 |
| Sp110 (Sp110 nuclear body protein) | Male/Female | 3 | 23 | Hematological System | Log2 | 10.0 | <0.001 |
| Spata17 (spermatogenesis associated 17) | Male/Female | 2 | 26 | Lung | Log2 | 30.0 | <0.001 |
| Spats2 (spermatogenesis associated, serine-rich 2) | Male/Female | 3 | 23 | Hematological System | Log2 | 20.0 | <0.001 |
| Spg20 (spastic paraplegia 20, spartin (Troyer syndrome) homolog (human)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 11.0 | <0.001 |
| Spg21 (spastic paraplegia 21 homolog (human)) | Male/Female | 5 | 30 | Kidney | Log2 | -5.0 | <0.001 |
| Spint2 (serine protease inhibitor, Kunitz type 2) | Male/Female | 8 | 24 | Muscle | Log2 | 6.0 | <0.001 |
| Sqle (squalene epoxidase) | Male/Female | 6 | 22 | Liver | Log2 | 26.0 | <0.001 |
| Srgn (serglycin) | Male/Female | 2 | 26 | Lung | Log2 | 5.0 | <0.001 |
| Ssrp1 (structure specific recognition protein 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -3.0 | <0.001 |
| St3gal3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) | Male/Female | 6 | 22 | Liver | Log2 | 25.0 | <0.001 |
| Stat5a (signal transducer and activator of transcription 5A) | Male/Female | 3 | 23 | Hematological System | Log2 | 7.0 | <0.001 |
| Stbd1 (starch binding domain 1) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 17.0 | <0.001 |
| Stfa2l1 (stefin A2 like 1) | Male/Female | 2 | 26 | Lung | Log2 | 53.0 | <0.001 |
| Stmn1 (stathmin 1) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| Stmn2 (stathmin-like 2) | Male/Female | 3 | 23 | Hematological System | Log2 | 97.0 | <0.001 |
| Sts (steroid sulfatase) | Male/Female | 8 | 24 | Muscle | Log2 | 27.0 | <0.001 |
| Stx1a (syntaxin 1A (brain)) | Male/Female | 5 | 30 | Anatomical System | Log2 | -3.0 | <0.001 |
| Svs4 (seminal vesicle secretory protein 4) | Male/Female | 5 | 22 | Brain | Log2 | 2642.0 | <0.001 |
| Synm (synemin, intermediate filament protein) | Male/Female | 3 | 23 | Hematological System | Log2 | 66.0 | <0.001 |
| Tbl1x (transducin (beta)-like 1 X-linked) | Male/Female | 8 | 24 | Muscle | Log2 | 2.0 | <0.001 |
| Tcfcp2l1 (transcription factor CP2-like 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 5.0 | <0.001 |
| Tcfcp2l1 (transcription factor CP2-like 1) | Male/Female | 2 | 26 | Lung | Log2 | -6.0 | <0.001 |
| Tcfe3 (transcription factor E3) | Male/Female | 2 | 26 | Lung | Log2 | -3.0 | <0.001 |
| Tcra (T-cell receptor alpha chain) | Male/Female | 2 | 26 | Lung | Log2 | 17.0 | <0.001 |
| Tfdp1 (transcription factor Dp 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Tff3 (trefoil factor 3, intestinal) | Male/Female | 6 | 22 | Liver | Log2 | 97.0 | <0.001 |
| Thbs3 (thrombospondin 3) | Male/Female | 2 | 26 | Lung | Log2 | -12.0 | <0.001 |
| Thy1 (thymus cell antigen 1, theta) | Male/Female | 2 | 26 | Lung | Log2 | 15.0 | <0.001 |
| Tm2d2 (TM2 domain containing 2) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Tmed7 (transmembrane emp24 protein transport domain containing 7) | Male/Female | 8 | 24 | Muscle | Log2 | 5.0 | <0.001 |
| Tmem100 (transmembrane protein 100) | Male/Female | 8 | 24 | Muscle | Log2 | 13.0 | <0.001 |
| Tmem158 (transmembrane protein 158) | Male/Female | 3 | 23 | Hematological System | Log2 | 16.0 | <0.001 |
| Tmsb10 (thymosin, beta 10) | Male/Female | 5 | 30 | Kidney | Log2 | 12.0 | <0.001 |
| Tmx1 (thioredoxin-related transmembrane protein 1) | Male/Female | 8 | 24 | Muscle | Log2 | 4.0 | <0.001 |
| Tnfaip2 (tumor necrosis factor, alpha-induced protein 2) | Male/Female | 3 | 23 | Hematological System | Log2 | 14.0 | <0.001 |
| Tnfrsf13c (tumor necrosis factor receptor superfamily, member 13c) | Male/Female | 3 | 23 | Hematological System | Log2 | -22.0 | <0.001 |
| Tpd52l1 (tumor protein D52-like 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Trf (transferrin) | Male/Female | 8 | 24 | Muscle | Log2 | 11.0 | <0.001 |
| Trim43a (tripartite motif-containing 43A) | Male/Female | 6 | 22 | Liver | Log2 | -5.0 | <0.001 |
| Trim46 (tripartite motif-containing 46) | Male/Female | 3 | 23 | Hematological System | Log2 | 19.0 | <0.001 |
| Trmt5 (TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)) | Male/Female | 2 | 26 | Lung | Log2 | 8.0 | <0.001 |
| Trmt61a (tRNA methyltransferase 61 homolog A (S. cerevisiae)) | Male/Female | 5 | 22 | Brain | Log2 | 6.0 | <0.001 |
| Trpt1 (tRNA phosphotransferase 1) | Male/Female | 2 | 26 | Lung | Log2 | 12.0 | <0.001 |
| Ttc18 (tetratricopeptide repeat domain 18) | Male/Female | 2 | 26 | Lung | Log2 | 9.0 | <0.001 |
| Tubg1 (tubulin, gamma 1) | Male/Female | 2 | 15 | Hippocampus | Log2 | -4.0 | <0.001 |
| Ubac1 (ubiquitin associated domain containing 1) | Male/Female | 5 | 30 | Kidney | Log2 | -3.0 | <0.001 |
| Ube2g1 (ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans)) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -2.0 | <0.001 |
| Ube2l3 (ubiquitin-conjugating enzyme E2L 3) | Male/Female | 8 | 24 | Muscle | Log2 | -2.0 | <0.001 |
| Ubqln4 (ubiquilin 4) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Usp37 (ubiquitin specific peptidase 37) | Male/Female | 5 | 22 | Brain | Log2 | 7.0 | <0.001 |
| Vamp2 (vesicle-associated membrane protein 2) | Male/Female | 5 | 30 | Kidney | Log2 | -39.0 | <0.001 |
| Vasn (vasorin) | Male/Female | 3 | 23 | Hematological System | Log2 | -10.0 | <0.001 |
| Vtn (vitronectin) | Male/Female | 5 | 30 | Anatomical System | Log2 | 4.0 | <0.001 |
| Wdfy4 (WD repeat and FYVE domain containing 4) | Male/Female | 3 | 23 | Hematological System | Log2 | -10.0 | <0.001 |
| Wdr31 (WD repeat domain 31) | Male/Female | 2 | 26 | Lung | Log2 | 11.0 | <0.001 |
| Wdr4 (WD repeat domain 4) | Male/Female | 8 | 24 | Muscle | Log2 | -5.0 | <0.001 |
| Wisp1 (WNT1 inducible signaling pathway protein 1) | Male/Female | 2 | 26 | Lung | Log2 | -20.0 | <0.001 |
| Wnt10a (wingless related MMTV integration site 10a) | Male/Female | 4 | 15 | Cochlea | Log2 | 16.0 | <0.001 |
| Wnt4 (wingless-related MMTV integration site 4) | Male/Female | 3 | 23 | Hematological System | Log2 | 44.0 | <0.001 |
| Wnt5a (wingless-related MMTV integration site 5A) | Male/Female | 3 | 23 | Hematological System | Log2 | 34.0 | <0.001 |
| Wwc1 (WW, C2 and coiled-coil domain containing 1) | Male/Female | 5 | 30 | Kidney | Log2 | 11.0 | <0.001 |
| Xiap (X-linked inhibitor of apoptosis) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -13.0 | <0.001 |
| Zbtb16 (zinc finger and BTB domain containing 16) | Male/Female | 2 | 15 | Hippocampus | Log2 | 2.0 | <0.001 |
| Zc3hav1 (zinc finger CCCH type, antiviral 1) | Male/Female | 3 | 23 | Hematological System | Log2 | -5.0 | <0.001 |
| Zcchc18 (zinc finger, CCHC domain containing 18) | Male/Female | 2 | 26 | Lung | Log2 | 14.0 | <0.001 |
| Zfhx3 (zinc finger homeobox 3) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| Zfp251 (zinc finger protein 251) | Male/Female | 2 | 26 | Lung | Log2 | -4.0 | <0.001 |
| Zfp62 (zinc finger protein 62) | Male/Female | 8 | 24 | Muscle | Log2 | 6.0 | <0.001 |
| Zfp64 (zinc finger protein 64) | Male/Female | 5 | 22 | Brain | Log2 | 5.0 | <0.001 |
| Zfp651 (zinc finger protein 651) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | 7.0 | <0.001 |
| Zfp68 (zinc finger protein 68) | Male/Female | 5 | 22 | Brain | Log2 | 5.0 | <0.001 |
| Zfp84 (zinc finger protein 84) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Zmym1 (zinc finger, MYM domain containing 1) | Male/Female | 2 | 26 | Lung | Log2 | -10.0 | <0.001 |
| Znrd1 (zinc ribbon domain containing, 1) | Male/Female | 2 | 26 | Lung | Log2 | -2.0 | <0.001 |
| Zzz3 (zinc finger, ZZ domain containing 3) | Male/Female | 5 | 25 | Skeletal Muscle | Log2 | -12.0 | <0.001 |
| Reference:Digital Aging Atlas |